Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

SmithKline Beecham describes LTB4 antagonists for psoriasis

July 11, 1997

Korean researchers discover new melanin synthesis inhibitors

July 10, 1997

Dovonex cleared for use in children in the U.K.

July 9, 1997

Dermatologic and Ophthalmic Drugs Advisory Committee meets July 14-15, 1997

July 8, 1997

Prostacyclin derivative in development for skin ulcers

July 7, 1997

Hyal's treatment for sun spots approved in the U.K.

July 3, 1997

Celtrix's SomatoKine enters phase II feasibility study for the treatment of burns

July 2, 1997

Cellegy's antiwrinkling product enters clinical trials

July 1, 1997

Preclinical results with Anika's INCERT promising

July 1, 1997

Antipruritogenic effect of Kochia Fructus extract and active components

June 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...